Author: Professor Mark Lawler

As the Brexit debate ramps up in advance of the referendum on 23 June, Professor Mark Lawler looks at how cancer researchers and patients in the UK have benefitted from EU support and collaboration and he examines the possible ramifications of a Brexit vote on cancer care and research.